| Financial Year |
March 31 2023 |
| Monetary Funds |
798,008,443.29 |
| Held-for-trading Financial Assets |
29,582.85 |
| Notes Receivable |
96,135,270.89 |
| Accounts Receivable |
1,259,255,965.65 |
| Advances to Suppliers |
40,787,952.23 |
| Other Receivables |
11,858,589.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
461,993,311.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
52,101,534.24 |
| Other Current Assets |
127,833,652.72 |
| Total Current Assets |
2,995,213,054.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,691,698.18 |
| Fixed Assetes |
1,103,786,037.79 |
| Under-construction Projects |
295,243,152.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
1,495,357.53 |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
73,874,633.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
571,373.52 |
| Deferred Income Tax Assets |
43,441,854.93 |
| Other Non-Current Assets |
557,048,546.82 |
| Sub-Total of Non-Current Assets |
2,134,380,245.26 |
| Total Assets |
5,129,593,299.49 |
| Short-Term Loans |
2,621,849,637.45 |
| Trading Financial liabilities |
2,907.50 |
| Notes Payable |
10,000,000.00 |
| Accounts Payable |
278,343,581.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,558,474.18 |
| Taxes Payable |
34,543,373.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
66,449,880.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,316,478.87 |
| Other Current Liabilities |
1,347,308.79 |
| Sub-Total of Current Liabilities |
3,057,775,555.39 |
| Long-term Loans |
98,930,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,603,377.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
152,516,303.52 |
| Total Liabilities |
3,210,291,858.91 |
| Paid-In Capital(Or Share Stock) |
147,622,137.00 |
| Capital Surplus |
1,340,153,965.83 |
| Surplus Reserve |
18,464,907.86 |
| LESS:Treasury Stock |
57,661,460.00 |
| Undistributed Profits |
470,721,889.89 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,919,301,440.58 |
| Owner's Equity（Stockholder's Equity） |
1,919,301,440.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,129,593,299.49 |
